Robert DiBianco, MD
Robert
DiBianco, MD
This Summary (updated 4/05)
includes:
Birth Date: December 20, 1946 CME disclosure Statement -page
5
Born: Brooklyn, New York 67 Abstracts
Citizenship: USA 62 Reviews, Chaps etc.
48
Original
contributions
Current
Positions: Biographical sketch -page 24
Associate Clinical Professor of Medicine,
Georgetown University, School of Medicine,
Washington, DC
and
Active Medical Staff
Washington Adventist Hospital Additional
Professional Titles:
Takoma Park, Maryland FACC-Fellow of the American
College of Cardiology
FACP-Fellow
of the American College of Physicians
FAHA-Fellow
of the American Heart Association
7901 Maple Avenue 15215
Shady Grove Road, Suite 306
Takoma Park, Maryland 20912 Rockville, MD
20850
Telephone: 301-891-7000 Telephone 301-990-0040
FAX: 301-
891-7009 FAX:
301-990-0043
Home address Email: DrDiBianco@aol.com
4914 30th Place, N.W. Home Telephone: 202-363-2293
Washington, DC 20008-1016 Home
FAX 202-362-6982
24-Hr Voice Mail: 301-891-5490
Digital
Pager: 301- 224-5214
Cell:
240-793-9670
I am happily married to Joan Marie Bowen DiBianco,
RN, MSN (since October 29, 1977 )
Children: David Anthony (born December 5, 1981)
John-Michael (born
September 23, 1985)
Regina Marie (born August l,
1993)
Education
1961-64 Erasmus
Hall High School, Brooklyn, New York
1964-68 Brooklyn
College of the City University of New York Bachelor of Science (Major:
Chemistry)
1968-72 State
University of New York at Buffalo, School of Medicine Doctor of Medicine Degree
Honors: Alpha Omega Alpha Honor
Medical Society ,
James A. Gibson Anatomical Society, Honors Member David K. Miller Award in Medicine
1972-73 SUNY/Buffalo
Affiliated Hospitals (E.J. Meyer Memorial County Hospital, Buffalo General Community Hospital, and the
Veterans Administration Hospital,
Buffalo, New York)
Straight Medical Internship
Honors: First Annual Norman Chassin
MD Award for Excellence
1973-74 First
Year Medical Residency, SUNY/Buffalo Affiliated Hospital
1974-75 Chief
Medical Resident, SUNY/Buffalo Affiliated Hospitals
1975-77 Fellowship
in Cardiology, Georgetown University and Veterans Administration Hospital Fellowship Program, Washington, DC
Director, Division of Cardiology, W.
Proctor Harvey, MD
Chief of Cardiology, VA Hospital, Ross D. Fletcher, MD
1981-present Cardiology Consultant Staff,
Washington
Adventist Hospital, 7600 Carroll Avenue, Takoma Park, MD 20912
Shady Grove Adventist Hospital
, 9901 Medical Center Drive, Rockville, MD 20850
Committees: Washington Adventist Hospital
1982-1987 Coronary
Care Unit Committee
1981-2001 Institutional
Review and Research Committee
1981-2000 Medical Review Committee
1993-2000
Continuing
Medical Education, Chairman
1987-1992
Pharmacy
and Therapeutics Committee
1989-1992, Medical Executive Committee
2001-2004 Medical Executive Committee
1996-1998 Atorvastatin
vs revascularization treatment(AVERT) Study; Endpoints Committee, Chairman
1996-2003 Atorvastatin
vs usual care in CAD (ALLIANCE), Endpoints Committee, Chairman
1997-2000 PREVENT
trial, Endpoints committee member
1999-2003 Avasimibe
Vascular Clinical Trials, Endpoints Committee
1999-2004
CAMELOT
trial, Endpoints committee member
1999-present Novartis Cardiology Expert Advisory Panel
Activities:
1981-2004 Director, Cardiology Heart Failure
and Risk Factor Research
1986-present Full-time Cardiology Staff,
Washington Adventist Hospital
Takoma Park, Maryland 20912
1994-1999 Chairman, Medical Staff Capital
Campaign, Washington Adventist Hospital
1995-2000 Chairman, Continuing Medical
Education Committee
1994-2000 Board of Trustees, Washington
Adventist Foundation
1997-1999 Secretary to Medical and Dental
Staff, Washington Adventist Hospital
2001-2004 Chairman, Department of Medicine
Washington Adventist Hospital, 7600
Carroll Avenue, Takoma Park, MD 20912
1975-79 Lecturer, School of Nursing, Georgetown
University
1978-present American Heart Association
Basic
Cardiac Life Support [Past Instructor]
Advanced
Cardiac Life Support [Past Instructor]
Recertification,
Washington Adventist Hospital, 2004
1979-1983 American Heart Association (Nations
Capital Affiliate) Member, Professional Education
Committee Advisor,
Allied Health Prof Subcommittee Member,
Research Committee
1979 Consultant to Text: Textbook of
Medical-Surgical Nursing 4th Edition Brunner/Suddarth
1980-1990 Columbia Union College, Takoma Park,
MD 20912 Part-time Lecturer: Respiratory Therapy Courses
1980 Consultant to Text: Lippincott
Manual of Nursing Practice
1981-present Program Director,
Annual Cardiology Symposium for the
Primary Care Physician
-A CME Course in its 23rd
year in 2004, Washington,DC
1983 Consultant to Text: Cardiovascular
Nursing: Holistic Approach
1991-2003 Consultant Rodale Press, Board of
Advisors, Prevention Health Books
1995-present American Heart Association Spokesperson, News Media Relations
1996-2002 Medical Broadcasting Company,
www.pfizercme.com
1998-present Hypertension Network Registry of
Physicians, http://www.bloodpressure.com
1999-2002 Thomas
R. Beam Memorial Institute for CME, Education Advisory Board
2000-present Medical
Director, Adventist Home Health Services for District of Columbia
Past and Present Consulting or Manuscript Review:
American Journal of Cardiology
Hypertension
American Heart Journal
Drugs ADIS Press Ltd.
AMA Drug Evaluations, Heart and Vessels
New England Journal of Medicine
Annals of Internal Medicine
Cardiology Consultant to WUSA-TV Channel 9,
Washington, DC
Health
and Science Dept. Maria Checcia
(Producer)
Mid
Atlantic Medical Services, Inc. (MAMSI),
Adverse
Decision Panel
Chairman,
Cardiology Subspecialty Committee
Pharmacy and
Therapeutics Committee 1998-present
Journal of Heart Failure (Abstract reviews and
Editorial Board)
Alternative Therapies in Health and Medicine
Cardiology Review (Editorial Advisory Board)
Consultant to Rodale Press (Prevention Health Books)
Age Protectors-Stop Aging Now
Healing With Motion-health/healing and mind-body
exercises
The Doctors Book of Home Remedies
for Preventing Disease
Infections in Medicine, Editorial Board Member
Patient Care, Consultant for manuscript reviews
Journal of Heart Disease (Editorial Board)
Societies American
College of Physicians
American College of Cardiology
American Heart Association
International Society of Heart
Failure, Inc.
Heart Failure Society of America
Licensure District of
Columbia 11266
Maryland D 22846
Professional
Examinations
1.
National Board Certifying Examination #123480 –PASSED on first exam
Parts I, II, and III
2.
American Board of Internal Medicine Certifying Exam–PASSED on first exam
June ’75 Candidate Number
050195-Diplomate in Internal Medicine
3. American Board of
Internal Medicine -PASSED on first exam
October 18-19, 1977 Subspecialty Examination
in Cardiovascular Diseases
4. Re-certification
Examination in Electrocardiography -PASSED on first exam
June, 1997 American College
Cardiology
Disclosure Declaration for Robert DiBianco, M.D.
In compliance with the ACCME
guidelines to "insure balance, independence, objectivity and scientific
rigor in all its individually sponsored educational activities",
I disclose to all concerned
that I hold or have held the following relationships:
Speakers
Bureaus
(or sponsors of speaking activities I've been invited to give):
AstraZeneca Lecture Bureau
Boron LePore
Bristol-Myers Squibb
Covalent Group, Consultant for
Research, Contracting firm
Eli Lilly and Co.
Glaxo Smith Kline Beecham
Health Education Technologies-National
Speakers Program, Duke Univ. CME Office
Hoechst Marion Roussel
Pharmaceuticals -Medical Educ. Speakers Panel
Impact Communications, Inc.
(Academy for Healthcare Education)
ICHE, Institute for Continuing
Healthcare Education
KOS Pharmaceuticals, Inc.
MEDCON, Medical Education
Consultants, Westbury, CT
Merck and Co., Inc.
Novartis
Pharmaceuticals
Pfizer Pharmaceuticals
(Parke-Davis, Pratt Pharmaceuticals, Powers Pharmaceuticals)
Proctor and Gamble
Pharmaceuticals, Educator for Azimilide
QDHealthcare
Rhone-Poulenc
Rorer Pharmaceuticals, Speaker
Sanofi-Winthrop Laboratories
Schering
Corporation
Scios
Laboratories,
Vascular Biology Working Group,
Medical Education Consultants, Westport, CT
Grants for Research
Support (acting
as Director, Cardiology Heart Failure and Risk Factor Research, Washington
Adventist Hospital, Takoma Park, Maryland and Principal Investigator for
individual studies conducted by Cardiovascular Consultants, PA-until 2004)
Consultant for Legal, Commercial and Healthcare
interests (Past
and Present):
Chairman, Cardiology
Subspecialty Committee, MAMSI,
Rockville, MD,
Medical Advisors,
Philadelphia, PA; a legal consulting firm
Medically Dedicated
Incorporated (MDI), Washington, DC - a legal consulting firm,
WUSA, Channel 9 TV,
Washington, DC
Director and
Chairman of Annual Cardiology Symposium (1981-present)
Symposium participation by
all major pharmaceutical companies and cardiovascular product manufacturers
occurs on an annual basis for an all-day symposium to health care professionals
in metropolitan Washington, DC. Grants given solely for educational purposes go
to the symposium to offset costs to registrants.
Robert DiBianco, M.D.
1. DiBianco
R, Gottdiener JS, Fletcher RD, Pipberger HV: Left Atrial Over load - A
Hemodynamic, Echocardiographic,
Electrocardiographic and Vectorcardiographic Study.
Circulation
Part 2, Vol. 56 (4) Abstract 707, 1977
2. Gottdiener
JS, DiBianco R, Fletcher RD; Assessing Acute MI; Letter to the Editor.
Circulation
56:895-6, 1977.
3. Katz
RJ, Fletcher RD, DiBianco R, Del Negro A, Gorfinkel J: Sustained Parasympathetic Augmentation by Edrophonium: Electrophysiologic Studies .
Amer
Fed Clin Res 26(3):243A (Abstract) Apr. 1978.
4. Zarchy
TM, Chan CH, DiBianco R, Zeller J, Banda P, Hoffnagle JH: Peritoneovenous Shunt
for Intractable Ascites:
Complications. Gastroenterology 1169, May 1978 (Abstract).
5. DiBianco
R, Rosenfeld SP, Katz RJ, Simpson AG, Fletcher RD, Singh SN; Role of Aminophylline in Refractory Heart Failure: A
Comparison to the Vasodilator Sodium Nitroprusside.
Chest
76 (3): 351, Sept. 1979.
6. DiBianco
R, Dickie KJ, Singh SN, Katz RJ, Bortz R, Simpson AG, Spagnolo SV, Fletcher RD,
Raver JM: Pulmonary Effects of
a "Cardioselective" beta blocker.
Amer.
J. Cardiol 45:437, Feb. 1980.
7. Gottdiener
JS, DiBianco R, Fletcher RD, Bates R, Sauerbrunn BJ: Effects of Disopyramide on
Left Ventricular Function:
Assessment by Radionuclide Cineangiography.
Amer
Fed Clin Res 28 (2):175A, April 1980.
8. Fletcher
RD, Stillabower M, Schoolmeester WL, Singh SN, DiBianco R, Katz RJ, Del Negro A: Distinguishing Ventricular Ectopy from Aberrant
Conduction by Reproducing Aberrant Forms with Atrial
Stimulation. Amer Fed Clin Res 28 (2):169A, Apr. 1980.
9. DiBianco
R, Singh SN, Singh JB, Katz RJ, Bortz R, Gottdiener JS, Spodick DH, Laddu AR, Fletcher RD: Acebutolol Therapy for
Stable Angina Pectoris - A placebo-controlled, double-blind randomized cross-over study. Amer
Fed Clin Res 28 (2):166A, Apr. 1980
10. Pozen
R*, DiBianco R, Katz RJ, Bortz R, Fletcher RD: Metabolic Cost of Dobutamine for Congestive Heart Failure Complicating Coronary Artery
Disease.
Amer
Fed Clin Res 28 (2):203A, Apr. 1980. *Fellow
in Cardiology during research project.
11. Schoolmeester
WL, Fletcher RD, Simpson AG, R, Del Negro A: Non-invasive detenaination accessory pathways in
Wolff-Parkinson-White Amer Fed Clin Res 28 (2):209A, Apr. 1980
12. DiBianco
R, Gottdiener JS, Fletcher RD, Singh SN, Katz RJ, Sauerbrunn BJ Effects of
Encainide on Left Ventricular
Function: Assessment with Treadmill Exercise and Radionuclide Ventriculography.
Circulation
62 (Supplement III): 691, 1980.
13. Birnbaum
J, DiBianco R, Becker KL, Singh SN, Costello RB, Gottdiener JS, Fletcher RD:
Glucose and Lipid Metabolism
on Therapy with Acebutolol vs Propranolol in Non-diabetics.
Circulation
62 (Supplement III): 461; 198
14. Costello
RB*, DiBianco R; Singh SN, Gottdiener JS, Cockrell JL, Fletcher RD: Plasma catecholamines at Rest and Peak
Exercise in Patients with Chronic Angina. Circulation 62 (Supplement III): 471, 1980. *Masters in Biology student during
conduct of this research project.
15. Gottdiener
JS, DiBianco R, Fletcher RD, Bates HR, Sauerbrunn BJ: Effect of Disopyramide on
Left Ventricular Function:
Assessment by Radionuclide Cineangiography.
Circulation
62 (Supplement III): 556, 1980
16. Gottdiener
JS, Hawley RJ, DiBianco R, Fletcher RD, King-Engle W: Cardiac Manifestations in
Myotonia Atrophica.
Circulation 62 (Supplement III): 1227,1980. .
I7.
DiBianco R: Correlation Between Exercise Hemodynamics and Increased Magnitude
of P Terminal Force-Reply.
(Letter to Editor) Amer Heart J 100:590, 1980.
18. Katz
RJ, DiBianco R, Singh SN, Sauerbrunn BJ, Bates HR, Fletcher RD: Acebutolol, A
New Beta Blocker: Effects of
Resting and Exercise Ventricular Function in Coronary Artery Disease as Determined by Radionuclide
Angiography. J Nuc Med 21 (2): 65, 1980.
19. Fleischer
D, Phelps C, Wolfsheimer F, DiBianco R: Prevalence and Evaluation of Occult GI Bleeding in Patients on
Anticoagulants. Gastroenterology,1981.
20. DiBianco
R, Singh SN, Costello RB, Gottdiener JS, Cockrell JL, Fletcher RD: Acebutolol
Versus Propranolol for Stable
Angina Pectoris: Results of a Randomized Double-Blind Crossover Comparison. Am Fed Clin Res 29
(2):186A, 1981.
21. DiBianco
R, Singh SN, Albert M, Gottdiener JS, Laddu AR, Katz RJ, Johnso WL, Fletcher
RD: Long-term Prophylaxis of
Chronic Angina Pectoris by Acebutolol, a Cardioselective Beta Blocking Agent. Am Fed Clin Res 29 (2):186A,
1981.
22. DiBianco
R, Katz RJ, Fletcher RD, Costello RB, Simpson AG, Singh SN, Gottdiener JS:
Holter Recordings: A New
Validation Technique and Results of Testing.
Am
Fed Clin Res 29(2):186A, 1981.
23. Van
Voorhees L, Gottdiener JS, DiBianco R, Noss R, Rusk A, Bates R, Sauerbrunn BJ,
Fletcher RD: Effects of
Alcohol Ingestion on Left Ventricular Function in Normal Non-Alcoholic
Subjects.
Am
Fed Clin Res 29(2):284A, 1981.
24. Van Voorhees
L, Gottdiener JS, Gay J, DiBianco R, Maloney DL, Fletcher RD: The Effects of Alcohol on Left Ventricular
Relaxation and Systolic LV Function in Normal Subjects: chocardiographic Assessment by Compute Assisted Analysis
of LV Wall Velocity.
Am
Fed Clin Res 9(2):248A, 1981
25. Gottdiener
JS, Van Voorhees L, DiBianco R, Noss R, Bates R, Gay J, Sauerbrunn BJ, Fletcher
RD: Effects of Alcohol on Left
Ventricular Function in Patients with Coronary Artery Disease: Assessment by Radionuclide Cineangiography.
Am Fed Clin Res 29(2):197A, 1981.
26. Fletcher
RD, Keimel J, Larca L, Cox J, Del Negro A, DiBianco R, Singh SN
Non-Invasive
Serial Electrophysiologic Testing Using An Implanted Pace-maker to Track Chest Wall Stimuli. Am J Cardiology
47:392, 1981.
27. Gottdiener
JS, Van Voorhe.es L, Gay J, DiBianco R, Maloney DL, Fletcher RD: The Effect of Alcohol on Left Ventricular
Relaxation in Coronary Artery Disease: Echocardiographic Assessment by Computer Assisted Analysis of LV
Wall Velocity. Am J Cardiol 47:462, 1981.
28. Costello
RB*, Cockrell JL**,DiBianco R, Singh SN, Gottdiener JS, Fletcher RD, West WL:
Effects of Beta Blockade on Plasma
Prostaglandins in Chronic Angina Pectoris. Circulation
64 (Supplement IV):754, 1981.
Students: * Masters in Biology ;**2nd yr medical at time of research
29. DiBianco
R, Singh SN, Shah PM, Newman GC, Miller RR, Nahormek P, Costell RB, Cockrell
JL, Laddu AR, Gottdiener JS,
Fletcher RD: Antianginal Efficacy of Acebutolol and Propranolol: A Comparative Multicenter Study
Circulation 64 (Supplement IV):1132, 1981.
30. DiBianco
R, Fletcher RD, Cohen AI, Gottdiener JS, Singh SN, Katz RJ, Map AF, Cockrell
JL: Encainide Treatment of
Chronic Ventricular Arrhythmia: A Controlled Prospective Study. Circulation 64 (Supplement IV):1210,
1981.
31. Singh SN, DiBianco R, Fletcher RD, Johnson
W, Ginsberg R: Ethmozin Show Effective in Reducing Chronic High Frequency
Ventricular Arrhythmia: Results of a Prospective Controlled Trial. Amer J
Cardiol 49:1015, March 1982.
32. Gottdiener JS, Van Voorhees L, Gay
J, DiBianco R, Fletcher RD: Incidence and Embolic Potential of Left Ventricular Thrombus in Cardiomyopathy:
Assessment by Two-Dimensional Echocardiography. Am J Cardiol 49:1029, March
1982.
33. Singh
SN, DiBianco R, Davidov ME, Gottdiener JS, Johnson WL, Costello RB Fletcher RD:
Acebutolol Versus Propranolol
for Ventricular Ectopy: A Controlled, Randomized Double-Blind Crossover Study of Comparative
Efficacy. Amer Fed Clin Res 30(2):222A, April 1982.
34. DiBianco
R, Dickie KJ, Singh SN, Costello RB, Gottdiener JS, Laddu AR, Fletcher RD: The Pulmonary Effects of a
Cardiovascular Beta Blocker: Comparison to Propranolol and Placebo. Am Fed Clin Res 30(2):427A, Apri 1982.
35. DiBianco
R, Costello RB, Singh SN, Cockrell JL, Gottdiener JS, Fletcher RD: Effects of
Chronic Beta Blockade on
Plasma Catecholamines in Patients with Angina: Assessment at Rest and Maximal Exercise. Am Fed Clin Res
30(2):250A, April 1982.
36. Costello
RB, DiBianco R, Cockrell JS, Singh SN, Gottdiener JS, Fletcher RD; A Gradual
(2-Week) Withdrawal from Beta
Hlockade is Associated with the Early Normalization of Plasma Catecholamines. Am Fed Clin Res
30(2):180A, April 1982.
37. DiBianco
R, Fletcher RD, Mortara D, Cohen AI, Gottdiener JS, Singh S: The Non-Invasive Measurement of H-V Interval
Correlates with the Intra- cardiac Measurement Over a Wide Range of Encainide Induced Changes in
Infranodal Conduction Times in Man. Am Fed Cliri Res 30(2):183A, April 1982.
38. McWatters
J, Gottdiener JS, Mellow M, Sauerbrunn BJ, DiBianco R, Fletche rRD: Effects of
a Meal on Exertional Angina and Left
Ventricular Function in Patients with Coronary Artery Disease: Assessment by Radionuclide
Angiography. Am Fed Clin Res 30(2):205A, April 1982.
39. DiBianco
R, Ronan JA, Donohue DJ, Lindgren HI,i: Effects of a new oral slow release form
of isosorbide dinitrate on the
hemodynamics and exercise capacity of patients with angina: A placebo controlled and double blind study.
Circulation 66 (Suppl II): 1526, 1982
40. Gay
J, Gottdiener JS, DiBianco R, Fletcher RD: Right ventricular wall thickening in
systemic hypertension-
Echocardiographic determination of hypertrophic response in the
"non-stressed" ventricle.
J Am Coll Cardiol l: 593, 1983
41. DiBianco
R, Shabetai R, Silverman B, Leier C, Benotti J, Silverman ME, Steele P, Merrill
A, Weinstein NA, Brehm J,
Gerber L, Singh SN: Oral amrinone for congestive heart failure:
Preliminary
results of a multicenter, double-blind and placebo-controlled withdrawal.
J
Amer Coll Cardiol 1: 675, 1983
42. DiBianco
R, Alpert J, Katz RJ, Spann J, Chesler E, Ferri DP, Larca LJ, Costello RB,
Nugent HE, Eisenman M:
Antianginal efficacy of bepridil, a new long acting calcium channel blocker:
Results
of a 10 week, multicenter, placebo-controlled study. J Am Coll Cardiol 1: 692,
1983
43. Katz
RJ, DiBianco R, Chesler E, Alpert J, Spann J, Costello RB: Sustained beneficial
effect of bepridil in exertional
angina. Circulation III-402, 1983.
44. Singh
SN, DiBianco R, et al. Lorcainide for the treatment of Ventricular Arrhythmia:
Results of a double-blind and
placebo- controlled study. Circulation III-359, 1983
45. Gottdiener
JS, Gay JA, Wish MH, DiBianco R, Fletcher RD: 2D-Doppler Echo assessment of tricuspid regurgitation: Comparison
with Contrast Echocardiography. Circulation III-366, 1983
46. Fletcher RD, Cohen AI, Cohen R, Lee
B, Cutler DJ, DelNegro A, Singh S, DiBianco R. Efficacy of Noninvasive
electrophysiological testing in patients with implanted pacemakers to control
arrhythmia. J Am Coll Cardiol 3: 538, 1984
47. Papademetriou
V, Gottdiener JS, DiBianco R, Costello RB, Gay J, Fletcher R. Improvement of
left ventricular function by
bepridil: echocardiographic assessment by computer assisted analysis.
Clin
Pharm Ther 35: 265, 1984
48. Frishman
W, Crawford M, DiBianco R, Farnham D, Katz R, Kostis J, Mohiuddin S, Sawin H, Thadani U, Zellner S. Combination
propranolol- bepridil in stable angina pectoris:
A
multicenter study. Circulation Suppl II 1984: 70:171
49. Thadani
U, Shapiro W, DiBianco R. Effect of long-term placebo therapy on angina
frequency and exercise
tolerance in patients wlth stable angina pectoris. Circulation Suppl II 1984:
70:175
50. DiBianco
R, Thadani U, Smith V. Antianginal efficacy of nisoldipine: preliminary results
of a 12 week controlled, multicenter dose-ranging
study. Cardiovascular Pharmacotherapy International Symposium Abstracts 1: 11, April 1985
51. Thadani
U, Shapiro W, DiBianco R. Bepridil hydrochloride-Once a day calcium antagonist
in the treatment of angina
pectoris: A double-blind placebo controlled study. Cardiovascular Pharmacotherapy International
Symposium Abstracts 1: 251, April 1985
52. Thadani
U, Shapiro W, DiBianco ~. Effect of long term placebo therapy on angina
frequency and exercise
tolerance in patients with stable angina pectoris. Cardiovascular
Pharmacotherapy International
Symposium Abstracts 1: 489, April 1985
53. Massie
B, Bourassa M, DiBianco & Hess M, Krebs C, Likoff M, Konstam M, Packer M.
Multicenter controlled trial
of oral amrinone in congestive heart failure: lack of benefit compared to
placebo.
J
Am Coll Cardiol 5:514; February, 1985
54. DiBianco
R, Shabetai R, Kostuk W, Moran J, Schlant R, Wright R and the Milrinone
Multicenter Trial Group. Oral
milrinone and digoxin in heart failure: Results of a placebo-controlled,
prospective trial of each
agent and the combination. Circulation 1987; 76 (Suppl 4):256
55. Eichhorn EJ, Tandon PK, DiBianco R
Timmis GC, Fenster PE, Shannon J, Packer M on behalf of the Promise Study
Investigators and Coordinators. Clinical and prognostic significance of serum
magnesium concentration in patients with severe chronic congestive heart
failure.
The
PROMISE Study. J Am Coll Cardiol (suppl) 1993
56. Lang
RM, DiBianco. R, Broderick GT, Gottlieb SS, Kostis J, Lyle P, Makris L, Rajfer
SI, Rucinska EJ for the
Enalapril-captopril Investigators. First-dose effects of enalapril 2.5 mg and
captopril 6.25 mg in patients
with~heart failure: a double-blind, randomized, multicenter study.
International
Heart Failure Symposium Abstracts-1993
57. Pflugfelder
PW, Baird MG, Tonkon MJ, DiBianco R ,Pitt B for the Quinapril Heart Failure
Trial Investigators. Clin.
consequences of angiotensin-converting emzyme inhibitor withdrawal in chronic heart failure.. J Amer Coll
Cardiol 1993
58. Costello
RB, DiBianco R, Moser-Veillon PB. Magnesium status in patients with congestive
heart failure. J Am Col1 Nutr 1992:
9(5):5A
59. Sandow
K, Costello R, Johnson S, DiBianco R. Cholesterol screening: prime time to
target overweight at risk
individuals. J Am Coll Nutr 1992; 9(5):105A
60. Costello
RB, DiBianco R and Moser-Veillon PB. Response to magnesium supplementation in patients with congestive heart failure. J
Am Coll Nutr 1994; 13(15): 14
61. Costello
RB, DiBianco R, Moser-Veillon PB. Lack of response to magnesium supplementation.
Federation Proceedings 1994:
(8):A432
62. Oskoui
R, Van Voorhees LB, DiBianco R, Kiernan JM, Lindsay JJr. Thrombolytic therapy
and its relationship with
early ventricular septal rupture after myocardial infarction.
J
Am Coll Cardiol 1994
63. DiBianco,
R. Meta-analysis of pravastatin core
regression program: early clinical benefit.
Zeitschrift
fur Kardiologie (German Journal of Cardiology) 1995;84 (Supp 1):215 (Abstract
#752)
64. DiBianco
R, Pitt B. ACHIEVE: A new, large-scale, community-based study to assess
“high-dose” versus “low-dose” ACE inhibition with quinapril in heart
failure. J Heart Failure 1995;2:672
65.
DiBianco
R. ACEIs in Congestive Heart Failure: High dose, low dose, does it matter?
Heart Failure Society of America, Second Scientific Meeting, September 13, 1998
66.
DiBianco
R. Reducing Cardiovascular Events: Focus on Calcium Channel Blockers. J Heart Disease July, 2001;2 (1):477
67.
DiBianco
R. Reducing Cardiovascular Events: Focus on New Trials.
J Heart Disease July, 2003:3 (1): 292
(Educational/Instructional Papers,
Non-research contributions)
1. DiBianco
R. Changing Views of Angina Pectoris: A monograph for clinicians.
Parts
1 and 2, 1982
2. DiBianco
R. Amrinone in the management of congestive heart failure.
Cardiology
Product News 4: 1-14, January 1984
3. DiBianco R, Larca LJ, Singh SN,
Gottdiener JS, Fletcher RD. A comprehensive clinical review of the standard,
oral antiarrhythmic agents. Cardiovascular Reviews and Reports 6: 625-646; May
1985
4. DiBianco
R: Oral amrinone~for the treatment of patients with chronic congestive heart
failure. Cardiology Board
Review 2: 89-95, May/June 1985
5. DiBianco
R. Angiotensin converting enzyme inhibition: Unique and effective therapy for hypertension and congestive heart failure. Postgraduate Medicine 78: 229-248:
October, 1985
6. DiBianco
R, Gottdiener JS, Singh SN, Fletcher RD. A review of the effects of
disopyramide phosphate on left
ventricular function and the peripheral circulation. Angiology 38(2):174-183, Monograph Series 1987
7. DiBianco
R. The Bipyridine derivatives: amrinone and milrinone.
Chapter
7, In Text [Editor Carl Leier] Cardiotonic Drugs 1986
8. DiBianco
R. Adverse reactions with angiotensin converting enzyme (ACE) inhibitors.
Medical Toxicology 1: 122-141, 1986